Connor, Clark & Lunn Investment Management (CC&L)
ACHV icon

Connor, Clark & Lunn Investment Management (CC&L)’s Achieve Life Sciences ACHV Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-206
Closed -$548K – 819
2015
Q4 		$548K Sell
206
-9
-4% -$38K ﹤0.01% 525
2015
Q3 		$1.06M Buy
215
+25
+13% +$151K 0.01% 391
2015
Q2 		$975K Buy
190
+12
+7% +$59.5K 0.01% 343
2015
Q1 		$841K Buy
178
+90
+102% +$442K 0.01% 329
2014
Q4 		$445K Buy
88
+50
+132% +$244K ﹤0.01% 405
2014
Q3 		$222K Buy
+38
New +$264K ﹤0.01% 482

Other funds holding ACHV

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 39.77% 1-Year Est. Return
EGA
Eagle Global Advisors Houston, Texas $3.02B AUM 34.37% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s ACHV Position: Q1 2016 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Achieve Life Sciences (ACHV) in Q1 2016, closing a stake of 206 shares — an estimated $548K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in ACHV in Q3 2014 and held it in 6 quarters. The position peaked at $1.06M in Q3 2015. 38 funds tracked by Wall St. Rank hold ACHV as of Q1 2016.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Achieve Life Sciences position as of Q1 2016 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 206 Achieve Life Sciences shares in Q1 2016, an estimated $548K.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Achieve Life Sciences in Q3 2014 and held it in 6 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Achieve Life Sciences position peaked at $1.06M in Q3 2015.
  • 38 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q1 2016.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q1 2016, filed 13 May 2016.